Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) also known as Liver cancer is a primary malignancy disorder of the liver occurring primarily in patients with chronic hepatitis and other liver diseases. Hepatocellular carcinoma is the 3rd major leading cause of cancer-related deaths globally. The common symptoms are yellowish skin, severe abdominal swelling and pain, loss of appetite, weight loss, nausea, vomiting, and fatigue. People with chronic Hepatitis B and/ hepatitis C, patients with history of alcohol abuse, presence of aflatoxins, people with hemochromatosis, or with non-alcoholic steatohepatitis, type 2 diabetes, Wilson’s diseases, and Hemophilia, are at high risk of liver cancer. Treatment methods include surgical re-section, where surgeons remove the part of the liver having tumor while trying to preserve the healthy liver tissue. This method is not always desirable because only about 15% people globally are eligible for resection. Other most common treatment method is liver transplant. But, owing to the shortage of the organ with increasing list of patients for transplant, this option is not always recommended. The most common therapies prescribed by doctors are the Ablative therapies, viz., radiofrequency ablation (RFA), Cryo-ablation, Per-cutaneous ethanol injection, portal vein embolization, and potentially novel chemotherapeutic agents. These therapies help the patients in relieving the symptoms and provide relief. 

  • Liver diseases
  • Liver cirrhosis
  • Diabetes mellitus
  • Hepatic Screening and Imaging
  • Hepatic Pathology
  • Hepatic resection
  • Liver transplantation
  • Ablation therapies
  • Portal Vein Embolization

Related Conference of Hepatocellular Carcinoma

March 15-16, 2018

12th Global
Gastroenterologists Meeting

Barcelona, Spain
May 16-17, 2018

6th International Conference on Hepatology

Osaka, Japan
June 18-20, 2018

6th World Congress on Hepatitis & Liver Diseases

Dublin, Ireland
June 28-30, 2018

Euro Global Congress on HCV

Amsterdam, Netherlands
June 25-27, 2018

World Congress on Gastroenterology and Hepatology

Stockholm, Sweden
August 6-7, 2018

14th Annual Congress on Gastroenterology & Hepatology

Hyatt Regency Osaka, Japan
August 20-21, 2018

13th Euro-Global Gastroenterology Conference

Rome, Italy
September 7-8, 2018

18th World Gastroenterologists Summit

Auckland, New Zealand
September 10-11, 2018

17th World Digestive Diseases Conference

Bucharest, Romania
September 12-13, 2018

World Summit on Liver Cirrhosis and Hepatitis

Singapore
September 17-18, 2018
10 Plenary Forums - 1Event

3rd International Conference on Hepatobiliary & Pancreatic Disorders

Philadelphia, Pennsylvania, USA
October 15-16, 2018

3rd International Liver Conference

Abu Dhabi, UAE
Oct 22-24, 2018

3rd International conference on Digestive Diseases

| Berlin | Germany
October 29-30, 2018

4th World Congress on Digestive & Metabolic Diseases

| San Francisco, California, USA
October 29-30,2018

18th International Conference on Gastroenterology and Endoscopy

San Francisco, California, USA

Hepatocellular Carcinoma Conference Speakers

Recommended Sessions

Related Journals

Are you interested in